Skip to:

Marijuana has economic benefits, but public health risks are undecided

In a recent opinion piece published in The HillDr. Jonathan Fielding, distinguished professor of health policy and management at the UCLA Fielding School of Public Health, points out the lack of evidence behind health claims associated with marijuana. 

Wednesday, November 7, 2018

The marijuana business is booming in the U.S. medicinal marijuana is legal in 30 states and the District of Columbia. Eight states have legalized recreational marijuana. Sales figures are up wherever it is legally sold. In Colorado, for example, marijuana sales topped out at nearly $6B since 2014’s legalization. In 2017, sales there reached $1.5B and this year’s sales are on track to surpass that figure. This includes CBD (used medicinally — not the subject of this article) and plants with high levels of DTHC or THC, cannabis’s main psychoactive compound.

This is all excellent news for municipalities and states that benefit from increased tax revenues and for savvy marketers who now sell marijuana at the rate of alcohol. Unfortunately, marijuana’s public health risks are not as clearly understood as the risks of alcohol.

Read more in The Hill

Read more op-ed articles written by Dr. Fielding